2023-05-25T10:21:04Z
2023-01-01
2023-05-25T10:21:04Z
In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe physicochemical changes on the cell surface and confocal microscopy to determine how the liposomes interact with cell membranes and released their load. In addition, we performed viability assays using methotrexate as an active drug to obtain proof of concept of the formulation´s capacity to function as a drug delivery-system. The interaction of engineered liposomes with living cells corroborates the information obtained using model membranes and supports the capacity of the engineered liposomal formulation to serve as a potential nanocarrier.
Article
Versió publicada
Anglès
Liposomes; Sistemes d'alliberament de medicaments; Microscòpia de força atòmica; Liposomes; Drug delivery systems; Atomic force microscopy
Elsevier B.V.
Reproducció del document publicat a: https://doi.org/10.1016/j.colsurfb.2022.112968
Colloids and Surfaces B-Biointerfaces, 2023, vol. 221, p. 112968
https://doi.org/10.1016/j.colsurfb.2022.112968
cc-by-nc-nd (c) Elsevier B.V., 2023
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
Bioquímica i Biomedicina Molecular [916]
Bioquímica i Fisiologia [634]
Centres Científics i Tecnològics de la Universitat de Barcelona (CCiTUB) [75]
Enginyeria Electrònica i Biomèdica [779]
Farmàcia, Tecnologia Farmacèutica i Fisicoquímica [664]
Institut de Bioenginyeria de Catalunya (IBEC) [648]